Autologous Alpha-2 Macroglobulin Rich Plasma(Mayo Clinic)

N/A

Report date: 2024/03/28 13:04:35

Base Information

Drug NameAutologous Alpha-2 Macroglobulin Rich Plasma(Mayo Clinic)
Drug Alias NameAutologous Alpha-2 Macroglobulin Rich Plasma (A2MRP)
ClassificationBiologics > Blood components
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsOsteoarthritis, KneeOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesMayo Clinic
Inactive CompaniesN/A
Active IndicationsOsteoarthritis, KneeOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A